灵康药业集团股份有限公司关于控股股东部分股份办理质押的公告

Core Points - The announcement details the pledge of shares by the controlling shareholder, Lingkang Holdings Group Co., Ltd, which holds 33,965.28 million unrestricted circulating shares, accounting for 47.09% of the company's total share capital [2][3] - A total of 10,365.96 million shares have been pledged, representing 30.52% of the shares held by Lingkang Holdings and 14.37% of the company's total share capital [2][3] - The pledge risk is deemed controllable, with no risk of forced liquidation or margin call [3][4] Pledge Details - The pledged shares are not used as collateral for major asset restructuring or performance compensation [3] - Lingkang Holdings and its concerted parties have a cumulative pledge situation that is monitored [4] Impact on the Company - The credit status of Lingkang Holdings is good, and it has sufficient risk control capabilities, ensuring that the pledge will not affect the company's actual control, operational capacity, financing credit, financing costs, or corporate governance [4] - In the event of a liquidation risk, Lingkang Holdings will take measures such as additional pledges, margin increases, or early repayments to mitigate risks [4]